Yikilmaz, Taha Numan, Ayhan Dirim, Ebru Sebnem Ayva, Handan Ozdemir, and Hakan Ozkardes. “Clinical Use of Tumor Markers for the Detection and Prognosis of Bladder Carcinoma: A Comparison of CD44, Cytokeratin 20 and Survivin”. Urology Journal 13, no. 3 (June 28, 2016): 2677–2683. Accessed July 8, 2026. https://journals.sbmu.ac.ir/urolj/index.php/uj/article/view/3294.